Brief: Eloxx Pharmaceuticals Reports Q4 Loss Per Share $0.29

Eloxx Pharmaceuticals

05/03/2020 22:23

March 5 (Reuters) - Eloxx Pharmaceuticals Inc  ELOX.O :
    * ELOXX PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR
2019
FINANCIAL AND OPERATING RESULTS AND PROVIDES BUSINESS UPDATE
    * Q4 LOSS PER SHARE $0.29
    * Q4 EARNINGS PER SHARE ESTIMATE $-0.33 -- REFINITIV IBES
DATA
    * TOPLINE DATA FROM PHASE 2 CYSTIC FIBROSIS CLINICAL TRIALS
FOR
ELX-02 IN H1 2020

Source text for Eikon:  ID:nGNX5SlRw3 
Further company coverage:  ELOX.O 

 ((Reuters.Briefs@thomsonreuters.com;))